Bizelesin

比折来新

Report date: 2023/04/21 17:24:30

NME

Base Information

Drug NameBizelesin

Drug Alias NameNSC-615291U-77779

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAlkylating agentsDNA synthesis inhibitorsDNA inhibitors

TargetsDNA

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A